Biosimilars Market Size, Share, Key Trends, Research Analysis, and Future Forecast 2019 – 2030

November 16th, 2020 Releases

Biosimilars market was estimated to be over US$ 4,500 Mn in 2018. It is anticipated to grow at a CAGR of 31.4% from 2019 to 2030.

The growth of the biosimilars market can be attributed to factors such as the increasing demand for biosimilar drugs due to their cost-effectiveness and rising incidence of chronic diseases, which have led to wide-scale adoption of these products worldwide. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. For instance, PlantForm Corporationhas signed an agreement with the University of Guelph Canada to enhance research studies in the field of biosimilars and develop new ones.

Major Key Players of the Biosimilars Market are:
Pfizer, Sandoz International, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion, Samsung Biologics, Stada Arzneimittel AG and Mylan.

Download PDF to Know the Impact of COVID-19 on “Biosimilars Market” at: https://www.marketindustryreports.com/pdf/67?source=shubh

Over the years, the rise in demand of biosimilars has played a vital role in contributing to the growth of the global biosimilars industry. The high demand for biosimilars is attributed to their greater effectiveness and lower cost than other alternatives. Several countries, including Europe, North America, India, and other developing countries, have emerged as essential contributors to global biosimilars industry. While generic drugs have a profit margin potential of 20%, the biosimilars products is anticipated to gain a potential profit margin of 30%. Moreover, cost of treatment by innovator drug is much higher than that by biosimilars, which has also contributed effectively to the growing demand of these products.

The Surface Disinfectant Market is segmented on the basis of Type of Manufacturing, Disease and region.

Major Type of Manufacturing of Biosimilars Market covered are:

  • In-house Manufacturing
  • Contract Manufacturing

Major Applications of Biosimilars Market covered are:

  • Chronic Disease
  • Oncology
  • Autoimmune Disease,
  • Blood disorders
  • Infectious Diseases
  • Growth Hormone Deficiency

Changes in societal behavior and aging population have been contributing to the stable increase in long-term health problems, and treating these problems incurs a lot of cost. Rising incidence of chronic diseases have been pivotal in contributing the growing adoption of biosimilars worldwide. According to World health organization (WHO), in the UK, chronic disorders are likely to claim 5 million lives in the next 10 years, owing to rising incidences of these long-term ailments. Growing preference for biosimilars to treat chronic ailments is expected to further propel the growth of the biosimilars market in the coming years.

Research objectives:-

– To study and analyze the global Biosimilars consumption (value & volume) by key regions/countries, product type and application, history data.

– To understand the structure of the Biosimilars market by identifying its various sub-segments.

– Focuses on the key global Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.

– To analyze the Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.

– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Go For Interesting Discount Here: https://www.marketindustryreports.com/inquiry/67?source=shubh

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
    4. Market Estimation Methodology
    5. Data Validation and Triangulation
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Regulatory Landscape Assessment
    2. Pipeline  Assessment
    3. Epidemiological Assessment: Oncology
  6. GLOBAL BIOSIMILARS MARKET- ANALYSIS & FORECAST, BY PRODUCT
    1. Recombinant Glycosylated Proteins
      1. Monoclonal Antibodies
        1. Rituximab
        2. Adalimumab
        3. Infliximab
        4. Other Monoclonal Antibodies
      2. Erythropoietin
      3. Follitropin
    2. Recombinant Non-glycosylated Proteins
      1. Insulin
      2. Granulocyte Colony Stimulating Factor
      3. Recombinant Human Growth Hormone
      4. Interferons
        1. Interferon-Alpha
        2. Interferon-Beta
    3. Recombinant Peptide
      1. Glucagon
      2. Calcitonin
  7. GLOBAL BIOSIMILARS MARKET – ANALYSIS & FORECAST, BY TYPE OF MANUFACTURING
    1. Contract  Manufacturing
    2. In- house Manufacturing
  8. GLOBAL BIOSIMILARS MARKET – ANALYSIS & FORECAST, BY DISEASE
    1. Chronic Disease
    2. Oncology
    3. Autoimmune Disease
    4. Blood disorders
    5. Infectious Diseases
    6. Growth Hormone Deficiency
    7. Other Disease
  9. GLOBAL BIOSIMILARS MARKET – ANALYSIS & FORECAST, BY REGION
    1. North America Biosimilars Market
    2. Europe Biosimilars Market
    3. Asia Pacific Biosimilars Market
    4. Rest of the World (ROW) Biosimilars Market
  10. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  11. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1.  Pfizer
    2. Sandoz
    3. Teva Pharmaceuticals
    4. Amgen
    5. Biocon
    6. Dr. Reddy’s Laboratories
    7. Celltrion
    8. Samsung Biologics
    9. Stada Arzneimittel AG
    10. Mylan

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain

Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/67?source=shubh

In the end, Biosimilars industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.

About Market Industry Reports-

Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com

© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.